首页> 美国卫生研究院文献>other >Xiao-Shen-Formula a Traditional Chinese Medicine Improves Glomerular Hyper-Filtration in Diabetic Nephropathy via Inhibiting Arginase Activation and Heparanase Expression
【2h】

Xiao-Shen-Formula a Traditional Chinese Medicine Improves Glomerular Hyper-Filtration in Diabetic Nephropathy via Inhibiting Arginase Activation and Heparanase Expression

机译:中药小肾配方通过抑制精氨酸酶激活和乙酰肝素酶表达改善糖尿病肾病肾小球超滤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hyperglycemia induces glomerular hyper-filtration, which contributes to the development of diabetic nephropathy (DN), a condition that remains a challenge for treatment. The present study investigated the effect of Xiao-Shen-Formula (XSF) used for treatment of renal injury in type 1 DN mice model induced by streptozotocin (STZ) and its underlying mechanism in cultured human glomerular endothelial cell (hGECs). Studies were performed using control, diabetic DN, DN treated with XSF groups (1 g/kg/d, LXSF or 3 g/kg/d, HXSF) for 6 weeks and hGECs were post-treated with mice serum containing HXSF (MS-HXSF) and arginase inhibitor (ABH, 100 μM) in high glucose medium. HXSF treatment restored STZ-induced renal hyper-filtration, glomerulosclerosis, renal microvascular remodeling and the increased levels of systemic reactive oxidative species and inflammatory cytokines, accompanied by preventing the decreased expression of glomerular heparin sulfate and the increased levels of cortical heparanase and argianse2 protein and arginase activity. In hGECs study, MS-HXSF ameliorated the enhancement in arginase activity, the protein/mRNA expression of heparanase, mRNA levels of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, monocyte chemoattractant protein-1 and permeability of hGECs monolayers as well as the depression of nitric oxide production. Besides all these protective effects, XSF blunted the mRNA expression of TNF-α in vivo and vitro studies as well, which was not changed by the post-treatment of ABH or HXSF plus ABH. This study demonstrated that the protective effect of XSF might be related with vascular prevention, anti-inflammation and anti-oxidation through intervening multi-targets including glomerular endothelial arginase-heparanase signaling pathway in DN model.
机译:高血糖症会诱发肾小球超滤,从而导致糖尿病性肾病(DN)的发展,而糖尿病仍然是治疗的挑战。本研究调查了小肾公式(XSF)在链脲佐菌素(STZ)诱导的1型DN小鼠模型中治疗肾损伤的作用及其在培养的人肾小球内皮细胞(hGECs)中的潜在机制。使用对照组,糖尿病DN,XSF组(1 g / kg / d,LXSF或3 g / kg / d,HXSF)处理的DN进行研究6周,并用含HXSF的小鼠血清(MS- HXSF)和精氨酸酶抑制剂(ABH,100μM)在高葡萄糖培养基中。 HXSF治疗可恢复STZ诱导的肾过度滤过,肾小球硬化,肾微血管重塑以及全身性反应性氧化物质和炎性细胞因子水平的升高,并伴有预防肾小球硫酸盐肝素表达降低和皮质类肝素酶和精氨酸酶2和精氨酸酶活性。在hGECs研究中,MS-HXSF改善了精氨酸酶活性,乙酰肝素酶的蛋白/ mRNA表达,血管细胞粘附分子1的mRNA水平,细胞间粘附分子1,单核细胞趋化蛋白1以及hGECs单层的通透性。由于一氧化氮的产生而降低。除了所有这些保护作用外,XSF在体内和体外研究中均使TNF-α的mRNA表达减弱,但ABH或HXSF加ABH的后处理并没有改变。这项研究表明XSF的保护作用可能通过干预包括DN模型中的肾小球内皮精氨酸酶-乙酰肝素酶信号通路在内的多个靶点而与血管预防,抗炎和抗氧化有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号